We are developing an AI-powered digital intervention for Chronic Obstructive
Pulmonary Disease (COPD), aimed at improving outcomes at low cost.
Combining AI and brain-on-chip technology to cure Alzheimer's disease
In collaboration with two European CROs and one University, we are developing
AI/ML models/algorithms to speed up compound screening and improve lead optimization in
AI enrichment of biomarker services
We are developing AI/ML-based tools and models for improving biomarker
services, from automation of data integration to personalized prediction and recommendation of
evidence-based interventions synthesized by AI from constantly evolving evidence. We have
developed world-class algorithms for ultra-performance liquid chromatography (UPLC) and glycomics.